Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,456 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation and Update of the Lémann Index to Measure Cumulative Structural Bowel Damage in Crohn's Disease.
Pariente B, Torres J, Burisch J, Arebi N, Barberio B, Duricova D, Ellul P, Goldis A, Kaimakliotis I, Katsanos K, Krznaric Ž, McNamara D, Pedersen N, Sebastian S, Azahaf M, Weimers P, Lung P, Lacognata C, Horak M, Christodoulou D, Domislovic V, Murphy I, Lambert J, Ungaro R, Colombel JF, Mary JY. Pariente B, et al. Among authors: lambert j. Gastroenterology. 2021 Sep;161(3):853-864.e13. doi: 10.1053/j.gastro.2021.05.049. Epub 2021 May 28. Gastroenterology. 2021. PMID: 34052277 Free PMC article.
Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn's Disease in Sustained Remission.
Reenaers C, Mary JY, Nachury M, Bouhnik Y, Laharie D, Allez M, Fumery M, Amiot A, Savoye G, Altwegg R, Devos M, Malamut G, Bourreille A, Flourie B, Marteau P, Vuitton L, Coffin B, Viennot S, Lambert J, Colombel JF, Louis E; Groupe d'Etude Therapeutique des Affections Inflammatoires du tube Digestif. Reenaers C, et al. Among authors: lambert j. Clin Gastroenterol Hepatol. 2018 Feb;16(2):234-243.e2. doi: 10.1016/j.cgh.2017.09.061. Epub 2017 Oct 7. Clin Gastroenterol Hepatol. 2018. PMID: 28993262 Free article.
Efficacy and Safety of Infliximab Retreatment in Crohn's Disease: A Multicentre, Prospective, Observational Cohort (REGAIN) Study from the GETAID.
Boschetti G, Nachury M, Laharie D, Roblin X, Gilletta C, Aubourg A, Bourreille A, Zallot C, Hebuterne X, Buisson A, Grimaud JC, Bouhnik Y, Allez M, Altwegg R, Viennot S, Vuitton L, Carbonnel F, Paul S, Desseaux K, Lambert J, Peyrin-Biroulet L. Boschetti G, et al. Among authors: lambert j. Am J Gastroenterol. 2022 Sep 1;117(9):1482-1490. doi: 10.14309/ajg.0000000000001842. Epub 2022 Jun 2. Am J Gastroenterol. 2022. PMID: 35973142
Inflammatory bowel disease drastically affects the prognosis of patients treated for peritoneal metastases with combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A multicenter study.
Hammoudi N, Eveno C, Lambert J, Maillet M, Glehen O, Goere D, Lourenco N, Allez M, Aparicio T, Pocard M, Gornet JM; BIG-RENAPE working group. Hammoudi N, et al. Among authors: lambert j. Eur J Surg Oncol. 2018 Jun;44(6):799-804. doi: 10.1016/j.ejso.2018.03.006. Epub 2018 Mar 17. Eur J Surg Oncol. 2018. PMID: 29650418
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab.
Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Vuitton L, Moreau J, Amiot A, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Fumery M, Carbonnel F, Bommelaer G, Coffin B, Roblin X, van Assche G, Esteve M, Farkkila M, Gisbert JP, Marteau P, Nahon S, de Vos M, Lambert J, Mary JY, Louis E; Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Laharie D, et al. Among authors: lambert j. Gut. 2018 Feb;67(2):237-243. doi: 10.1136/gutjnl-2016-313060. Epub 2017 Jan 4. Gut. 2018. PMID: 28053054 Free article. Clinical Trial.
Adalimumab for patients with Crohn's disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study.
Pineton de Chambrun G, Pariente B, Seksik P, Altwegg R, Vuitton L, Stefasnescu C, Nancey S, Aubourg A, Serrero M, Peyrin-Biroulet L, Filippi J, Viennot S, Abitbol V, Boualit M, Boureille A, Moreau J, Buisson A, Roblin X, Nachury M, Zappa M, Lambert J, Bouhnik Y; GETAID-MICA study group. Pineton de Chambrun G, et al. Among authors: lambert j. J Crohns Colitis. 2019 Jan 25;13(Supplement_1):S616. doi: 10.1093/ecco-jcc/jjz045. J Crohns Colitis. 2019. PMID: 30794285
Prognosis of Lymphoma in Patients With Known Inflammatory Bowel Disease: A French Multicentre Cohort Study.
Severyns T, Kirchgesner J, Lambert J, Thieblemont C, Amiot A, Abitbol V, Treton X, Cazals-Hatem D, Malamut G, Coppo P, Galicier L, Walter-Petrich A, Deau-Fischer B, Besson C, Aparicio T, Beaugerie L, Allez M, Gornet JM. Severyns T, et al. Among authors: lambert j. J Crohns Colitis. 2020 Sep 16;14(9):1222-1230. doi: 10.1093/ecco-jcc/jjaa048. J Crohns Colitis. 2020. PMID: 32161943
Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity.
Charbonnel C, Convers-Domart R, Rigaudeau S, Taksin AL, Baron N, Lambert J, Ghez S, Georges JL, Farhat H, Lambert J, Rousselot P, Livarek B. Charbonnel C, et al. Among authors: lambert j. Eur Heart J Cardiovasc Imaging. 2017 Apr 1;18(4):392-401. doi: 10.1093/ehjci/jew223. Eur Heart J Cardiovasc Imaging. 2017. PMID: 28064155
3,456 results